TipRanks
Genmab A/S (DE:GE91)
FRANKFURT:GE91
Germany Market
GE91
Genmab
RESEARCH TOOLSreports

Genmab (GE91) Income Statement

3 Followers

Genmab Income Statement

Last quarter (Q2 2026), Genmab's total revenue was kr1.16B, an increase of 24.89% from the same quarter last year. In Q2, Genmab's net income was kr303.00M. See Genmab’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 3.72Bkr 21.53Bkr 16.47Bkr 14.51Bkr 8.42B
Gross Profit
$ 3.41Bkr 20.54Bkr 16.25Bkr 14.51Bkr 8.42B
Operating Expenses
$ 2.16Bkr 13.84Bkr 10.93Bkr 8.24Bkr 5.46B
Depreciation and Amortization
$ 71.06Mkr 413.00Mkr 240.00Mkr 362.00Mkr 250.00M
EBITDA
$ 1.34Bkr 9.70Bkr 5.95Bkr 7.35Bkr 4.18B
Operating Income
$ 1.25Bkr 6.70Bkr 5.32Bkr 6.27Bkr 2.95B
Other Income/Expenses
$ -46.04Mkr 2.46Bkr 316.00Mkr 678.00Mkr 965.00M
Pretax Income
$ 1.20Bkr 9.16Bkr 5.64Bkr 6.95Bkr 3.92B
Net Income
$ 963.76Mkr 7.84Bkr 4.35Bkr 5.45Bkr 2.96B
Per Share Metrics
Basic EPS
$ 1.55kr 12.14kr 6.60kr 8.34kr 4.52
Diluted EPS
$ 1.54kr 12.14kr 6.60kr 8.26kr 4.48
Weighted Average Shares Outstanding
 621.51M 646.33M 659.15M 653.87M 653.96M
Weighted Average Shares Outstanding (Diluted)
 626.92M 646.33M 659.15M 660.10M 660.46M

Genmab Earnings and Revenue History